Difference between revisions of "Dolasetron (Anzemet)"
Jump to navigation
Jump to search
m |
m (→Also known as) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
5-HT3 antagonist | 5-HT3 antagonist | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Generic name:''' dolasetron mesylate | ||
| + | *'''Brand name:''' Anzemet | ||
| + | |||
| + | [[Category:Drugs]] | ||
| + | [[Category:Intravenous medications]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Serotonin 5-HT3 antagonists]] | [[Category:Serotonin 5-HT3 antagonists]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1997]] |
Latest revision as of 15:24, 30 July 2020
Mechanism of action
5-HT3 antagonist
Also known as
- Generic name: dolasetron mesylate
- Brand name: Anzemet